Monoamine-induced diacylglycerol signaling rapidly accumulates Unc13 in nanoclusters for fast presynaptic potentiation

N Natalie Blaum (Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen) T Tina Ghelani (Molecular and Theoretical Neuroscience, Leibniz-Forschungsinstitut für Molekulare Pharmakologie) T Torsten W. B. Götz (Molecular and Theoretical Neuroscience, Leibniz-Forschungsinstitut für Molekulare Pharmakologie) K Keagan S. Chronister (Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen) M Mercedes Bengochea (Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen) L Livia Ceresnova (Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen) C Christian F. Christensen (Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen) T Thiago C. Moulin (Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen) H Hanna Kern (Functional Neurobiology, Institute of Developmental Biology and Neurobiology, Johannes Gutenberg University Mainz) U Ulrich Thomas (Department of Cellular Neurobiology, Leibniz Institute for Neurobiology) M Martin Heine (Functional Neurobiology, Institute of Developmental Biology and Neurobiology, Johannes Gutenberg University Mainz) S Stephan J. Sigrist (Institute for Biology and Genetics, Freie Universität Berlin) A Alexander M. Walter (Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen)

Abstract

Neuromodulators control mood, arousal, and behavior by inducing synaptic plasticity via G-protein-coupled receptors. While long-term presynaptic potentiation requires structural changes, mechanisms enabling potentiation within minutes remain unclear. Using the Drosophila neuromuscular junction, we show that octopamine, the invertebrate analog of norepinephrine, potentiates evoked neurotransmitter release on the timescale of one minute via a G-protein-coupled pathway involving presynaptic OAMB receptors and phospholipase C. This fast potentiation correlates with elevated signals of the release factor Unc13A and the scaffolding protein Bruchpilot. Live, single-molecule imaging of endogenously tagged Unc13 revealed its instantly reduced motility and increased concentration in synaptic nanoclusters with potentiation. Presynaptic knockdown of Unc13A fully blocked fast potentiation. Moreover, deleting its N-terminal localization sequence mislocalized the protein fragment to the cytosol, but still allowed for rapid plasma membrane recruitment by diacylglycerol (DAG) analog phorbol esters and octopamine, implicating a role of more C-terminal domains. A point mutation of endogenous Unc13 in its DAG-binding C1 domain blocked plasticity-induced nanoscopic enrichment and synaptic potentiation. The mutation increased basal neurotransmission but reduced Unc13 levels, revealing a gain of function and potential homeostatic compensation. The mutation also blocked phorbol ester–induced potentiation, decreased the calcium sensitivity of neurotransmission, and caused short-term synaptic depression. Homeostatic potentiation induced by postsynaptic receptor block mirrored octopamine-induced Unc13 recruitment and required presynaptic OAMB receptors, indicating overlapping machinery. Thus, rapid Unc13 immobilization and nanoscale compaction are salient features of fast presynaptic potentiation.

Article Details

Volume / Issue Vol. 122, Issue 34
Published August 26, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (13)

N

Natalie Blaum

Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen

T

Tina Ghelani

Molecular and Theoretical Neuroscience, Leibniz-Forschungsinstitut für Molekulare Pharmakologie

T

Torsten W. B. Götz

Molecular and Theoretical Neuroscience, Leibniz-Forschungsinstitut für Molekulare Pharmakologie

K

Keagan S. Chronister

Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen

M

Mercedes Bengochea

Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen

L

Livia Ceresnova

Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen

C

Christian F. Christensen

Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen

T

Thiago C. Moulin

Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen

H

Hanna Kern

Functional Neurobiology, Institute of Developmental Biology and Neurobiology, Johannes Gutenberg University Mainz

U

Ulrich Thomas

Department of Cellular Neurobiology, Leibniz Institute for Neurobiology

M

Martin Heine

Functional Neurobiology, Institute of Developmental Biology and Neurobiology, Johannes Gutenberg University Mainz

S

Stephan J. Sigrist

Institute for Biology and Genetics, Freie Universität Berlin

A

Alexander M. Walter

Molecular and Theoretical Neuroscience, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen